Luke Oh

749 total citations
11 papers, 655 citations indexed

About

Luke Oh is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Luke Oh has authored 11 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Cancer Research. Recurrent topics in Luke Oh's work include Signaling Pathways in Disease (3 papers), Neurogenesis and neuroplasticity mechanisms (3 papers) and Fibroblast Growth Factor Research (2 papers). Luke Oh is often cited by papers focused on Signaling Pathways in Disease (3 papers), Neurogenesis and neuroplasticity mechanisms (3 papers) and Fibroblast Growth Factor Research (2 papers). Luke Oh collaborates with scholars based in United States, Canada and Austria. Luke Oh's co-authors include V. Wee Yong, Dylan R. Edwards, Peter H. Larsen, Frances Donovan, Zena Werb, Craig A. Krekoski, Nora P. Dooley, Joon H. Uhm, Rashmi Bansal and David M. Ornitz and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Brain Research.

In The Last Decade

Luke Oh

11 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luke Oh United States 10 290 243 146 120 97 11 655
Jinxiang Dai United States 12 515 1.8× 257 1.1× 235 1.6× 91 0.8× 66 0.7× 14 941
Anton Novak Canada 5 786 2.7× 120 0.5× 153 1.0× 152 1.3× 45 0.5× 10 1.1k
Nora P. Dooley Canada 12 449 1.5× 343 1.4× 62 0.4× 91 0.8× 127 1.3× 14 1.1k
Virginia C. Hughes United States 5 642 2.2× 105 0.4× 115 0.8× 273 2.3× 74 0.8× 10 936
Ulrich Putz Australia 17 1.1k 3.9× 432 1.8× 56 0.4× 169 1.4× 50 0.5× 21 1.4k
Harwin Sidik Singapore 10 405 1.4× 86 0.4× 45 0.3× 131 1.1× 73 0.8× 16 618
Nan Hyung Hong United States 11 842 2.9× 430 1.8× 188 1.3× 119 1.0× 141 1.5× 19 1.3k
Yaël Gothelf Israel 16 291 1.0× 56 0.2× 84 0.6× 110 0.9× 41 0.4× 27 798
Ryan C. Winger United States 12 279 1.0× 175 0.7× 52 0.4× 60 0.5× 147 1.5× 25 946
Zhicheng Mo United States 9 479 1.7× 59 0.2× 159 1.1× 147 1.2× 23 0.2× 12 856

Countries citing papers authored by Luke Oh

Since Specialization
Citations

This map shows the geographic impact of Luke Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Oh more than expected).

Fields of papers citing papers by Luke Oh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luke Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Oh. The network helps show where Luke Oh may publish in the future.

Co-authorship network of co-authors of Luke Oh

This figure shows the co-authorship network connecting the top 25 collaborators of Luke Oh. A scholar is included among the top collaborators of Luke Oh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke Oh. Luke Oh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Cusick, Matthew F., Jane E. Libbey, Luke Oh, Shaun Jordan, & Robert S. Fujinami. (2014). Acthar gel treatment suppresses acute exacerbations in a murine model of relapsing-remitting multiple sclerosis. Autoimmunity. 48(4). 222–230. 14 indexed citations
3.
Jagessar, S. Anwar, Zahra Fagrouch, Nicole Heijmans, et al.. (2013). The Different Clinical Effects of Anti-BLyS, Anti-APRIL and Anti-CD20 Antibodies Point at a Critical Pathogenic Role of γ-Herpesvirus Infected B Cells in the Marmoset EAE Model. Journal of Neuroimmune Pharmacology. 8(3). 727–738. 32 indexed citations
4.
Luster, Troy A., Jeffrey A. Carrell, Yun Hee Cho, et al.. (2012). Fusion Toxin BLyS-Gelonin Inhibits Growth of Malignant Human B Cell Lines In Vitro and In Vivo. PLoS ONE. 7(10). e47361–e47361. 10 indexed citations
5.
Shoemaker, William J., Miki Furusho, Jack Rosenbluth, et al.. (2006). Mice with Conditional Inactivation of Fibroblast Growth Factor Receptor-2 Signaling in Oligodendrocytes Have Normal Myelin But Display Dramatic Hyperactivity when Combined with Cnp1 Inactivation. Journal of Neuroscience. 26(47). 12339–12350. 44 indexed citations
6.
Oh, Luke, et al.. (2003). Fibroblast Growth Factor Receptor 3 Signaling Regulates the Onset of Oligodendrocyte Terminal Differentiation. Journal of Neuroscience. 23(3). 883–894. 86 indexed citations
7.
Oh, Luke, Peter H. Larsen, Craig A. Krekoski, et al.. (1999). Matrix Metalloproteinase-9/Gelatinase B Is Required for Process Outgrowth by Oligodendrocytes. Journal of Neuroscience. 19(19). 8464–8475. 238 indexed citations
8.
Uhm, Joon H., Nora P. Dooley, Luke Oh, & V. Wee Yong. (1998). Oligodendrocytes utilize a matrix metalloproteinase, MMP-9, to extend processes along an astrocyte extracellular matrix. Glia. 22(1). 53–63. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026